According to Zacks, “Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities. The Company offers insulation for high temperature steam pipes, vessels, and equipment. Aspen serves petrochemical, refinery, industrial, and power generation sectors. It manufactures Cryogel (R), Pyrogel (R) and Spaceloft (R) products. Aspen Aerogels, Inc. is headquartered in Northborough, Massachusetts. “
ASPN has been the topic of a number of other research reports. Canaccord Genuity restated a buy rating on shares of Aspen Aerogels in a research note on Wednesday, June 22nd. Citigroup Inc. decreased their price target on Aspen Aerogels from $6.50 to $6.00 and set a buy rating on the stock in a research note on Thursday, July 7th. Craig Hallum began coverage on Aspen Aerogels in a research note on Tuesday, September 20th. They issued a buy rating and a $10.00 price target on the stock. Finally, JPMorgan Chase & Co. decreased their price target on Aspen Aerogels from $8.00 to $7.00 and set an overweight rating on the stock in a research note on Friday, August 5th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and an average price target of $7.70.
Aspen Aerogels (NYSE:ASPN) traded down 1.14% during midday trading on Wednesday, reaching $6.08. The company had a trading volume of 21,630 shares. The stock has a 50-day moving average price of $5.16 and a 200 day moving average price of $4.73. Aspen Aerogels has a 12-month low of $3.38 and a 12-month high of $8.87. The company’s market capitalization is $125.14 million.
Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Thursday, August 4th. The company reported ($0.02) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.02. Aspen Aerogels had a negative return on equity of 3.35% and a negative net margin of 3.14%. The firm had revenue of $27.70 million for the quarter, compared to analyst estimates of $30.99 million. During the same quarter last year, the company earned ($0.12) EPS. Equities analysts forecast that Aspen Aerogels will post ($0.31) EPS for the current year.
In other news, Director Richard F. Reilly acquired 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 23rd. The shares were bought at an average price of $4.82 per share, with a total value of $48,200.00. Following the acquisition, the director now directly owns 36,178 shares in the company, valued at approximately $174,377.96. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William P. Noglows acquired 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 24th. The shares were purchased at an average cost of $4.98 per share, for a total transaction of $99,600.00. Following the acquisition, the director now owns 46,178 shares in the company, valued at $229,966.44. The disclosure for this purchase can be found here. Corporate insiders own 14.70% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in ASPN. Tocqueville Asset Management L.P. increased its position in shares of Aspen Aerogels by 35.1% in the second quarter. Tocqueville Asset Management L.P. now owns 657,080 shares of the company’s stock valued at $3,266,000 after buying an additional 170,650 shares during the last quarter. Wall Street Associates increased its position in shares of Aspen Aerogels by 28.8% in the second quarter. Wall Street Associates now owns 566,200 shares of the company’s stock valued at $2,814,000 after buying an additional 126,774 shares during the last quarter. Heartland Advisors Inc. bought a new position in shares of Aspen Aerogels during the second quarter valued at approximately $497,000. Ameriprise Financial Inc. increased its position in shares of Aspen Aerogels by 12.9% in the second quarter. Ameriprise Financial Inc. now owns 872,629 shares of the company’s stock valued at $4,338,000 after buying an additional 99,600 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. bought a new position in shares of Aspen Aerogels during the first quarter valued at approximately $371,000. 76.10% of the stock is currently owned by hedge funds and other institutional investors.
About Aspen Aerogels
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with MarketBeat.com's FREE daily email newsletter.